Sean F. Scanlan - 08 Mar 2025 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Innovation Officer
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
08 Mar 2025
Net transactions value
$0
Form type
4
Filing time
11 Mar 2025, 21:00:11 UTC
Previous filing
24 Jan 2025
Next filing
19 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Tax liability $0 -401 -0.11% $0.000000 365,477 08 Mar 2025 Direct F1
transaction TMCI Common Stock Tax liability $0 -1,396 -0.38% $0.000000 364,081 10 Mar 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 330,829 restricted stock units.
F2 Includes 325,098 restricted stock units.